Aim: Neferine is an isoquinoline alkaloid isolated from seed embryos of Nelumbo nucifera (Gaertn), which has a variety of biological activities. In this study we examined the effects of neferine on Kv4.3 channels, a major contributor to the transient outward current (I to ) in rabbit heart, and on ex vivo electrophysiology of rabbit hearts. Methods: Whole-cell Kv4.3 currents were recorded in HEK293 cells expressing human cardiac Kv4.3 channels using patch-clamp technique. Arterially perfused wedges of rabbit left ventricles (LV) were prepared, and transmembrane action potentials were simultaneously recorded from epicardial (Epi) and endocardial (Endo) sites with floating microelectrodes together with transmural electrocardiography (ECG). Results: Neferine (0.1-100 μmol/L) dose-dependently and reversibly inhibited Kv4.3 currents (the IC 50 value was 8.437 μmol/L, and the maximal inhibition at 100 μmol/L was 44.12%). Neferine (10 μmol/L) caused a positive shift of the steady-state activation curve of Kv4.3 currents, and a negative shift of the steady-state inactivation curve. Furthermore, neferine (10 μmol/L) accelerated the inactivation but not the activation of Kv4.3 currents, and markedly slowed the recovery of Kv4.3 currents from inactivation. Neferineinduced blocking of Kv4.3 currents was frequency-dependent. In arterially perfused wedges of rabbit LV, neferine (1, 3, and 10 μmol/L) dose-dependently prolonged the QT intervals and action potential durations (APD) at both Epi and Endo sites, and caused dramatic increase of APD 10 at Epi sites. Conclusion: Neferine inhibits Kv4.3 channels likely by blocking the open state and inactivating state channels, which contributes to neferine-induced dramatic increase of APD 10 at Epi sites of rabbit heart.
Introduction
The activity of voltage-dependent K + (Kv) channels regulates the threshold, shape, duration, and frequency of action potentials in a wide variety of excitable cells [1] . A transient outward current (I to )-mediated phase 1, which gives rise to a notched appearance of the action potential (AP), is now well established to be more prominent in the epicardium than in the endocardium of the ventricles of many species [2] . The presence of a prominent AP notch in the epicardium but not in the endocardium causes a transmural voltage gradient during ventricular activation that has been shown to underlie the J-wave and J-point elevation in the ECG [3] . The presence of a prominent I to -mediated notch also predisposes the ventricular epicardium to all-or-none repolarization under a variety of conditions, including ischemia [4] [5] [6] . A loss of the AP dome (plateau) in the epicardium but not in the endocardium produces a voltage gradient during ventricular repolarization that is believed to underlie the elevation of the ST segment [3] . Native I to is encoded by A-type K + -channel genes, such as Kv1.4, Kv4.2, and Kv4.3 [7] [8] [9] . The participation of Kv4 .3 has been convincingly demonstrated in rats [8] , rabbits [7] , dogs [9] and 1452 www.nature.com/aps Wang C et al Acta Pharmacologica Sinica npg humans [7] . Moreover, experimental studies of antisense oligodeoxynucleotides have also shown that Kv4.3 alone is a major component of I to in the human and canine heart, whereas a combination of three cloned channels, Kv4.2, Kv4.3, and Kv1.4, is responsible for I to in the rabbit atrium, which suggests that the physiological differences between the human and rabbit I to may reflect the differential expression of subunit genes in K + channels [7, 10] . Seed embryos from Nelumbo nucifera (Gaertn), also known as lotus, have been used in Chinese clinical practice as a traditional medicine for cardiovascular disease for over one thousand years. Neferine, which is an isoquinoline alkaloid ingredient in seed embryos from Nelumbo nucifera (Gaertn), has been demonstrated to have a wide range of biological activities, including preventing the onset of reentrant ventricular tachycardias after myocardial ischemia [11] [12] [13] [14] . However, reports of the effects of neferine on ion channels are sparse. Li et al first reported that neferine may inhibit the slow transmembrane Na + and/or L-type Ca 2+ current in myocardium [15] . Moreover, the direct effects of neferine on the human ether-a-go-gorelated gene potassium current were recently reported by Gu et al [16] and Dong et al [17] . However, detailed studies of the interaction between neferine and I to have not yet been published.
The present study aimed to determine the effects of neferine on Kv4.3 channels and the underlying potential effects of neferine on cardiac electrophysiology.
Materials and methods
Cell culture HEK293 cells stably expressing the human cardiac Kv4.3 channel (a kind gift from Prof Gui-rong LI, University of Hong Kong) were maintained in Dulbecco's modified Eagle's medium (DMEM, HyClone) containing 10% (v/v) fetal bovine serum (FBS, Gibco) and 500 μg/mL G418 (Sigma-Aldrich) at 37 °C in 5% CO 2 -enriched air. The cells were seeded on sterile glass coverslips for 24−48 h before patch-clamp experiments.
Solutions and drugs
The extracellular bath solution contained the following (in mmol/L): 140 NaCl, 5 KCl, 1.8 CaCl 2 , 1 MgCl 2 , 0.33 NaH 2 PO 4 , 10 HEPES, and 10 glucose (pH adjusted to 7.3 with NaOH). The pipette solution contained the following (in mmol/L): 20 KCl, 110 K-aspartate, 1 MgCl 2 , 10 HEPES, 5 Mg-ATP, 5 EGTA, 5 Na 2 -phosphocreatine, and 0.1 GTP (pH adjusted to 7.2 with KOH). Neferine (purity≥97%, measured by HPLC) was provided by the Department of Pharmacology's Phytochemistry Laboratory of Tongji Medical College at the Huazhong University of Science and Technology (Wuhan, China) [18] . It was dissolved in HCl and diluted with deionized water to obtain a 10 mmol/L stock solution (pH adjusted to 6.8 with NaOH). Quindine (Sigma) was dissolved in dimethyl sulfoxide (DMSO) to prepare a stock solution of 100 mmol/L. The stock solutions were stored at -20 °C and diluted with the bath solution to obtain the desired concentration. The concentration of DMSO in the final dilution was less than 0.1%, and this concentration did not affect the Kv4.3 currents.
Patch-clamp recording
The Kv4.3 currents were recorded using the standard wholecell patch-clamp technique. Cells on a cover slip were transferred to an open cell chamber mounted on the stage of an inverted microscope and superfused with bath solution at approximately 2 mL/min. Glass pipettes (1.5 mm diameter) were pulled with a two-stage microelectrode puller (PC-10, Narishige, Japan), and the resistance of the pipettes ranged from 2 to 4 MΩ when filled with the internal solution. The membrane currents were recorded with an EPC-10 amplifier and Pulse software (HEKA Electronik, Lambrecht, Germany) at room temperature (21−23 °C). The liquid junction potentials between the pipette and bath solutions were compensated before the pipette touched the cell. After giga-seal, the membrane was ruptured by gentle suction to establish the wholecell configuration. The whole-cell capacitance and resistance were compensated, and the leak currents were subtracted. The current signal was filtered at 3 kHz and sampled at 10 kHz. Currents were recorded 5 min after achieving a wholecell patch-clamp configuration.
Arterially perfused wedge of rabbit left ventricle
The methods used for surgical preparation, isolation, perfusion, and the recording of transmembrane activity from the arterially perfused rabbit left ventricle wedge preparation and the methods used to ensure the viability and electrical stability of the preparation were previously published and exactly followed [19, 20] . Briefly, male New Zealand white rabbits weighing 2.5 to 3.0 kg were anticoagulated with 800 U/kg heparin (iv) and anesthetized with pentobarbital (50 mg/kg, iv). The rabbit's heart was rapidly excised and submerged in cold (4 °C) cardioplegic solution containing 24 mmol/L K + buffered with 95% O 2 and 5% CO 2 . The left circumflex or anterior descending branch of the coronary artery was cannulated and perfused with the same cardioplegic solution. The unperfused areas of the left ventricle were removed and identified based on their reddish appearance. The preparation was then placed in a small heated tissue bath and arterially perfused with normal Tyrode's solution containing 4 mmol/L K + buffered with 95% O 2 and 5% CO 2 , maintained at 35.76±0.2 °C; the perfusion pressure was maintained at 35 to 45 mmHg. The ventricular wedge was allowed to equilibrate in the tissue bath for 1 h prior to the electrical recordings. The preparation was paced at basic cycle lengths (BCLs) of 1000 ms.
A transmural pseudo-ECG was recorded with a pair of silver/ silver chloride electrodes along the same vector as the transmembrane recordings. The transmembrane action potentials were recorded simultaneously from epicardial (Epi) and endocardial (Endo) sites with floating glass microelectrodes filled with 2.7 mol/L KCl. All amplified signals were digitized, stored on hard disk and analyzed using RM6240 (Chengdu, China). The action potential duration (APD) was measured at 90%, 50%, 20% and 10% of repolarization (APD 90 , APD 50 , APD 20 and APD 10 ).
Statistical analysis
The current was analyzed using Pulsefit (HEKA), and 1453 www.chinaphar.com Wang C et al Acta Pharmacologica Sinica npg nonlinear curve fitting was performed using SigmaPlot11.0 (SPSS Science, Chicago, IL, USA). Values are presented as the mean±SEM. Paired Student's t-tests were used to evaluate the significance of differences between two groups, whereas ANOVA was used to compare multiple groups. Values of P<0.05 indicated significant differences.
Results
Effects of neferine on Kv4.3 channels Kv4.3 currents were evoked by a single 500-ms depolarizing pulse to +50 mV from a holding potential of -80 mV. Superfusion with 10 μmol/L neferine significantly inhibited Kv4.3 currents ( Figure 1A ). The inhibitory effects of neferine on Kv4.3 currents were similar to those of quinidine: 10 μmol/L neferine reduced the peak outward currents by approximately 25.71%±1.23%, whereas 10 μmol/L quinidine reduced the peak outward currents by approximately 30.10%±4.01% (n=7, P>0.05) ( Figure 1A and 1B). The concentration-dependent inhibition of Kv4.3 currents was investigated using 0.1−100 μmol/L neferine. The peak amplitudes of Kv4.3 currents at different concentrations of neferine were normalized to the fractional block percent relative to the control and then plotted against the concentration of neferine (n=5−8 for each concentration). The concentration-response curve was fitted to the Hill equation:
n ], where B(%) is the fractional block percent change of the peak amplitude of Kv4.3 currents at a given neferine concentration [D] , IC 50 is the concentration for 50% of maximum effect, and n is the Hill coefficient. The IC 50 of neferine was 8.437 μmol/L for a Hill coefficient of 0.8605 ( Figure 1C ), and these parameters are similar to those of quinidine reported by Singarayar et al [21] . Figure 2A shows the voltage-dependent blocking of Kv4.3 by neferine. Kv4.3 currents were evoked by 500-ms pulses ranging from -80 to +50 mV in steps of 10 mV every 5 s from Figure 2B illustrates the currentvoltage (I-V) relationships of Kv4.3 currents before and after the application of 3, 10, 30 μmol/L neferine and washout (n=6, P<0.05).
The effects of 10 μmol/L neferine on the steady-state activation of Kv4.3 channels were examined using double-pulse protocols. The amplitudes of tail currents were measured at -60 mV after the application of 8 ms depolarizing pulses stepping from -80 mV to +100 mV in 20 mV increments every 5 s from a holding potential of -80 mV. Figure 2C shows the summarized data for the activation in the absence and presence of 10 μmol/L neferine. The steady-state activation curve was fitted to the Boltzmann equation: I/I max =a/{1+exp[-(V-V 1/2 )/k]}, where I max represents the current measured at the most depolarized preconditioning pulse, V is the test potential, V 1/2 represents the point at which channels were half-activated, and k is the Effects of neferine on steady-state inactivation of Kv4.3 channels The voltage dependence of the steady-state inactivation of Kv4.3 currents was determined using a conventional doublepulse protocol: holding the membrane potential at -80 mV and then stepping from -120 mV to +50 mV for 500 ms with increments of 10 mV followed by a 500-ms depolarizing pulse to +50 mV at 5 s intervals ( Figure 3A) . The Boltzmann equation was fitted to the steady-state inactivation curve: (I-I 0 )/ (I max -I 0 )=a/[1+exp(V-V 1/2 )/k], where I max represents the current measured at the most hyperpolarized preconditioning pulse, I 0 represents a non-inactivating current at the most depolarized preconditioning pulse, and V 1/2 represents the point at which channels were half-inactivated. The steady-state inactivation curve was negatively shifted by 10 μmol/L neferine ( Figure  3B ): the V 1/2 value of the control was -30.18±7.13 mV, whereas that of 10 μmol/L neferine was -37.85±7.92 mV (n=5, P<0.05); the slope factor was 11.67±2.33 for the control and 9.36±0.93 for 10 μmol/L neferine (n=5, P>0.05).
Effects of neferine on the time constants of activation and inactivation The time constants of activation (from the start of depolarizing pulses to the peak) and inactivation (from the peak to the end Figure 3 . Effects of neferine on steady-state inactivation of Kv4.3 channels. (A) Representative traces show the steady-state inactivation of Kv4.3 currents, which were evoked using a two-pulse protocol. The membrane potential was held at -80 mV and then stepped from -120 to +50 mV in 500 ms in increments of 10 mV followed by a 500-ms depolarizing pulse to +50 mV in the absence or presence of 10 μmol/L neferine. (B) Steady-state inactivation curves of Kv4.3 currents were fitted to the Boltzmann equation; the plots represent the normalized peak currents during the test pulse as a function of the conditioning potential (n=5, P<0.05). The data are expressed as the mean±SEM.
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Acta Pharmacologica Sinica npg of depolarizing pulses) of Kv4.3 currents fit a single-exponential function well. The activation time constants were not altered ( Figure 4A , n=7, P>0.05), whereas 10 μmol/L neferine decreased the inactivation time constants at test potential from +10 mV to +50 mV (the inactivation time constants were decreased from 102.52±4.57 ms for control to 92.02±3.85 ms at +50 mV) ( Figure 4B, n=7, P<0 .05).
Frequency-dependent effects of neferine on Kv4.3 currents The frequency dependence of the effect of neferine was evaluated using 10 consecutive 200-ms depoplarizing pulses to +50 mV from a holding potential of -80 mV at 0.5, 1 and 2 Hz ( Figure 5A ). The amplitude elicited by the second to tenth episode of the train was normalized to that elicited by the first episode and plotted against the given frequency ( Figure 5B ). The reduction in the first depolarizing pulse was considered to be the tonic block, and the reduction in subsequent pulses was considered to be frequency-dependent inhibition [22] . The tonic blocks of 10 μmol/L neferine were 24.79%±1.47% at 0.5 Hz, 24.95%±1.25% at 1 Hz and 24.63%±1.46% at 2 Hz (n=5, P>0.05). Consistent with a previous observation [1] , significant decreases in the Kv4.3 current were observed at 1 and 2 Hz (compared with that of the first episode). The frequencydependent inhibition of the Kv4.3 current by 10 μmol/L neferine was observed at a frequency ≥ 1 Hz. The block of Kv4.3 current at the tenth stimulus of the train increased from 26.98%±1.61% at 0.5 Hz to 28.96%± 1.49% at 1 Hz (n=5, P<0.05) and 33.08%±1.37% at 2 Hz (n=5, P<0.01) ( Figure 5C ).
Effects of neferine on the time course of recovery from inactivation
The increase in blocking by neferine at faster rates suggests a time-dependent recovery after repolarization. The time course of recovery from inactivation was determined using a doublepulse protocol. The cells were depolarized to +50 mV for 500 ms (P1) from a holding potential of -80 mV, then returned to the holding potential for a variable time interval between 50 and 5000 ms, followed by a second 500-ms pulse to +50 mV (P2) ( Figure 6A ). The peak amplitude of the second pulse (P2) was normalized to the corresponding first peak (P1) amplitude. The normalized data were plotted against the interpulse interval. The recovery curve fitted a single-exponential function well: y=y 0 +A 1 [1-exp(-t/τ)], where τ represents the time course of the recovery from inactivation. A dose of 10 μmol/L neferine significantly slowed the recovery from the inactivation of Kv4.3 current and increased the τ from 278.08± 30.52 ms to 331.40±30.82 ms (n=6, P<0.05) (Figure 6B and 6C) .
Effects of neferine on the transmembrane action potentials and QT intervals
Neferine elicited a concentration-dependent (1−10 μmol/L) lengthening of the action potential duration (APD) (Figure 7B Figure 7C . The effects of neferine on the APD 10 at Epi sites were stronger than that at Endo sites. The APD 10 at Epi sites increased approximately 566.96%±103.64%, whereas the APD 10 at Endo sites increased only 117.98%±25.44% in response to 10 μmol/L neferine. The dispersion of APD 10 (the difference 
Discussion
This study yielded the following novel findings: (1) Neferine potently and reversibly inhibits Kv4.3 currents in a concentra- www.nature.com/aps Wang C et al Acta Pharmacologica Sinica npg tion-dependent and frequency-dependent manner; (2) neferine significantly shifts the steady-state activation curve of Kv4.3 currents in a positive direction while shifting the steadystate inactivation curve in a negative direction; (3) neferine accelerates the inactivation and decelerates the recovery from the inactivation of Kv4.3 currents; (4) neferine significantly prolongs the QT intervals and APD at Epi and Endo sites in rabbit left ventricle wedges, especially the APD 10 , which was dramatically extended at Epi sites. The present work demonstrates that neferine is a potent direct blocker of I to and may contribute to the ability of neferine to dramatically increase the APD 10 at Epi sites. Kv4.3 channels, which are members of the shal-type rapidly activating and inactivating Kv channels, encode the transient outward potassium currents (I to ) in the heart [9] , which are responsible for phase 1 of the cardiac action potential [23] . I to is altered in many heart diseases and is consequently a target of many drugs [24, 25] . The present study indicated that neferine potently inhibited K v 4.3 currents in a concentration-dependent manner, with a half-maximal inhibition (IC 50 ) of 8.437 μmol/L ( Figure 1C) . Recent pharmacokinetic and tissue distribution measurements in rats showed that the concentration of neferine in the heart was 11.1±6.8 µmol/L 30 min after a tail vein injection of 25 mg/kg neferine [26] . Therefore, the concentration of neferine needed to block Kv4.3 channels can be achieved.
In the present study, neferine treatment resulted in the frequency-dependent inhibition of Kv4.3 currents and a subsequent slow recovery from this inactivation. Frequencydependent blocking is the most common characteristic of [21, 27] , flecanide [27] , nicardipine [1] . Accelerated blocking suggests that depolarization enhances the drug's effect on the channel and that time-dependent recovery occurs after inactivation. The characteristics of the frequency-dependent blocking suggest that neferine is another open-channel blocker of Kv4.3 channels.
Neferine accelerated the inactivation of Kv4.3 channels and significantly negatively shifted the steady state inactivation curve, which is similar to the quinidine-induced blocking of Kv4.3 currents [21] . However, the ability of open channel blockers to shift the inactivation curve has been debated. Wang et al [27] suggested that the accelerated inactivation without a shift in the voltage dependence of inactivation in the quinidineinduced blocking of the Kv4.3 current is consistent with openchannel blockade, whereas a negative shift in the voltage dependence of inactivation in the flecainide-induced blocking of Kv4.3 current is consistent with a preferential inactivatedchannel blockade. However, Singarayar et al reported a negative shift in the voltage dependence of the quinidine-induced blocking of Kv4.3 currents [21] (the contradicting effects of quinidine on the Kv4.3 current inactivation curve may not be due to the differences in the cells used in these studies). Other agents that act as open-channel blockers of Kv4.3, such as dapoxetine [28] and duloxetine [29] , also negatively shifted the voltage dependence of inactivation of the Kv4.3 current. These apparently open channel blockers can also bind to the inactivated state of channels. A similar effect on other channels has also been observed for other open channel blockers such as pergolide that negatively shifted the voltage dependence of inactivation of Kv1.5 currents [30] , and BAPTA-AM and ketaserin, which negatively shifted the voltage dependence of the inactivation of hERG currents [31, 32] . This effect may be attributed to the following: Kv4.3 currents, like I Kv1.5 [30] and I hERG [32] , are characterized by a current window in which the steadystate activation curve and inactivation curve overlap, which allows neferine to simultaneously bind the open state and the inactivated state of channels, like other open channel blockers. Unlike the quinidine-induced blocking of Kv4.3 currents, which did not shift the steady state activation curve [21] , neferine shifted the steady state activation curve of Kv4.3 currents in a depolarizing direction. A positive shift in the steady state activation curve of Kv4.3 currents suggested that the reactivation of the channel was difficult upon the binding of neferine.
I to -mediated phase 1, which gives rise to a notched appearance of the action potential (AP), is more prominent in the epicardium than the endocardium of the ventricles of many species [2] . Kv4.2, Kv4.3, and Kv1.4 are the major constituents of native cardiac I to in the rabbit atrium [7] . The ability of neferine to block the Kv4.3 current might assist the observed lengthening of cardiac APD 10 , APD 20 and QT intervals. Because of the differences in the distribution of I to between the epicardium and endocardium of the ventricles, neferine dramatically increased APD 10 at Epi sites. Neferine preferentially prolongs the initial repolarization and the subsequent plateau phases, which is consistent with the participation of I to in early phases of repolarization. The blockade of I to may also explain the neferine-induced decrease of the dispersion of APD 10 because neferine may shrink the voltage gradients between epicardial and endocardial sites. These effects may prevent phase 2 reentry and contribute to prevent the onset of reentrant ventricular tachycardia after myocardial ischemia. However, the excessive blocking of I to could also be proarrhythmic. Obviously, the anti-arrhythmic consequences of neferine action on I to await further study.
In conclusion, neferine is a potent inhibitor of Kv4.3 channels that likely functions by blocking the open state and inactivating the state of channels. This action may contribute to the ability of neferine to dramatically increase the APD 10 at Epi sites.
